Fed. Circ. Wary Of Undoing Endo Loss Over Vasostrict Fight
By Khorri Atkinson ( July 7, 2022, 6:13 PM EDT) -- Two Federal Circuit judges on Thursday repeatedly pushed back on an Endo International unit's assertion that a Delaware federal judge erroneously declined to stop Eagle Pharmaceuticals Inc. from launching a generic version of blood pressure medication Vasostrict after finding that Endo's newer patents covering the blockbuster drug wouldn't be infringed. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.